Analysts have been eager to weigh in on the Financial sector with new ratings on Metlife (MET – Research Report) and Ally Financial (ALLY – ...

Palantir’s valuation has cooled after the selloff, while demand and profitability trends have sharply improved. Learn why PLTR stock is upgraded to a buy.

In a report released today, Alex Scott from Barclays maintained a Buy rating on Metlife (MET – Research Report), with a price target of $88.00.

In the afternoon, Poland is scheduled to publish trade and current account data.

This upward trend is evident, with the current average reflecting a 1.28% increase from the previous average price target of $94.89. A clear picture of MetLife's perception ... Typically, analysts ...

We recently published a list of the 10 Best Insurance Stocks to Buy According to Hedge Funds. In this article, we are going ...

The president said many countries have been negotiating with Washington and they will try and make "fair deals" with each of ...

Traders make money from short selling if the price of the stock falls and they lose if it rises ... As you can see from the ...

The S&P 500 has lost 11% the past two sessions in the steepest two-day slide since March 2020, when the Covid pandemic pushed ...

At the same time, the company's stock is caught up in the escalating trade war hitting the whole market. Trump's announcement of significant tariffs on nearly all of U.S. trading partners was met ...

MetLife (NYSE:MET – Get Free Report) had its price target upped by research analysts at UBS Group from $94.00 to $98.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has ...